Curevo Vaccine to present at the 42nd Annual J.P. Morgan Healthcare Conference

<p>SEATTLE, Dec. 21, 2023 (GLOBE NEWSWIRE) — Curevo Vaccine (Curevo), a privately held clinical-stage biotechnology company dedicated to reducing the burden of infectious disease by developing safe and highly-effective vaccines, today announced it has been selected to present in the Private Company Track at the 42nd Annual J.P. Morgan Healthcare Conference. Curevo’s CEO, George Simeon, […]</p>
<p>The post <a href="https://forextv.com/top-news/curevo-vaccine-to-present-at-the-42nd-annual-j-p-morgan-healthcare-conference/">Curevo Vaccine to present at the 42nd Annual J.P. Morgan Healthcare Conference</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>